Literature DB >> 23098617

Retrograde ejaculation after anterior lumbar interbody fusion with and without bone morphogenetic protein-2 augmentation: a 10-year cohort controlled study.

Garet C Comer1, Micah W Smith, Eric L Hurwitz, Kyle A Mitsunaga, Robert Kessler, Eugene J Carragee.   

Abstract

BACKGROUND CONTEXT: Retrograde ejaculation (RE) is a complication of anterior lumbar interbody fusion (ALIF) techniques. Most commonly, this results from mechanical or inflammatory injury to the superior hypogastric plexus near the aortic bifurcation. Bone morphogenetic protein-2 (BMP-2) has been used in spinal fusions and has been associated with inflammatory and neuroinflammatory adverse reactions, which may contribute to RE development after anterior lumbar surgery.
PURPOSE: While controlling for anterior approach technique, we compared the incidence of RE with and without rhBMP-2 exposure, in large, matched cohorts of patients after ALIF. STUDY
DESIGN: Retrospective analysis of 10 years of prospectively gathered outcomes data on consecutive-patient cohorts having the same anterior exposure technique for ALIF with and without rhBMP-2 use. PATIENT SAMPLE: All male patients without baseline sexual incapacity and having ALIF for lumbar spondylosis or spondylolisthesis of the lowest one or two lumbar levels with and without rhBMP-2, from 2002 through 2011. OUTCOME MEASURES: Diagnosis of RE as a new finding after ALIF compared against BMP-2 exposure, comorbid conditions, and other urological complications after ALIF surgery.
METHODS: From the comprehensive surgical database at a high volume, university practice, male subjects having ALIF at one (L5/S1) or two levels (L4/5, L5/S1) from 2002 to 2011 were identified. Baseline comorbid factors, postoperative urinary catheter/retention events, and RE events were recorded and comparative incidence compared.
RESULTS: There were four consecutive-patient cohorts identified: one before rhBMP-2 use was adopted (n=174), two cohorts in which BMP-2 use was routine (n=88 and n=151), and one final cohort after BMP-2 use was discontinued from routine use (n=59). The cohorts with and without BMP-2 exposure were closely comparable for age, approach, levels of surgery, comorbid factors affecting RE. Of 239 patients with ALIF and exposure to BMP-2, RE was diagnosed in 15 subjects (6.3%), compared with an RE diagnosis rate of two of 233 control patients without BMP-2 exposure (0.9%; p=.0012). Urinary retention after bladder catheter removal was also more frequently observed in patients exposed to BMP-2 (9.7%) compared with control patients (4.6%; p=.043). Of the baseline comorbid factors, medical or surgical treatment for prostatic hypertrophy disease was associated with an increased risk of RE in the BMP-2 patients (p=.034).
CONCLUSIONS: This study confirms previous reports of a higher rate of RE in ALIF procedures using rhBMP-2 and an open anterior approach to the spine. This effect may be associated with an increased risk of postoperative urinary retention after BMP-2 exposure. The magnitude of the RE effect may be increased with concomitant prostatic disease treatments.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23098617     DOI: 10.1016/j.spinee.2012.09.040

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  34 in total

Review 1.  Current status of bone graft options for anterior interbody fusion of the cervical and lumbar spine.

Authors:  Anthony Minh Tien Chau; Lileane Liang Xu; Johnny Ho-Yin Wong; Ralph Jasper Mobbs
Journal:  Neurosurg Rev       Date:  2013-06-07       Impact factor: 3.042

2.  Bio-augmented spinal fusion-the best is yet to come.

Authors:  Julia Vavken
Journal:  J Spine Surg       Date:  2016-12

3.  Sexual activity after spine surgery: a systematic review.

Authors:  Azeem Tariq Malik; Nikhil Jain; Jeffery Kim; Safdar N Khan; Elizabeth Yu
Journal:  Eur Spine J       Date:  2018-05-23       Impact factor: 3.134

4.  Access related complications during anterior exposure of the lumbar spine.

Authors:  Gary A Fantini; Abhijit Y Pawar
Journal:  World J Orthop       Date:  2013-01-18

Review 5.  The potential impact of bone tissue engineering in the clinic.

Authors:  Ruchi Mishra; Tyler Bishop; Ian L Valerio; John P Fisher; David Dean
Journal:  Regen Med       Date:  2016-08-23       Impact factor: 3.806

Review 6.  Comparison of ALIF vs. XLIF for L4/5 interbody fusion: pros, cons, and literature review.

Authors:  Mark J Winder; Shanu Gambhir
Journal:  J Spine Surg       Date:  2016-03

7.  Lumbar interbody fusion with utilization of recombinant human bone morphogenetic protein: a retrospective real-life study about 277 patients.

Authors:  Stéphane Litrico; Tristan Langlais; Florent Pennes; Antoine Gennari; Philippe Paquis
Journal:  Neurosurg Rev       Date:  2017-03-10       Impact factor: 3.042

8.  Epidemiologic trends in the utilization, demographics, and cost of bone morphogenetic protein in spinal fusions.

Authors:  Philip K Louie; Hamid Hassanzadeh; Kern Singh
Journal:  Curr Rev Musculoskelet Med       Date:  2014-09

9.  An awake, minimally-invasive, fully-endoscopic surgical technique for treating lumbar radiculopathy secondary to heterotopic foraminal bone formation after a minimally invasive transforaminal lumbar interbody fusion with BMP: technical note.

Authors:  Albert Edward Telfeian
Journal:  J Spine Surg       Date:  2018-03

10.  Cell-Mediated Dexamethasone Release from Semi-IPNs Stimulates Osteogenic Differentiation of Encapsulated Mesenchymal Stem Cells.

Authors:  Sooneon Bae; Ho-Joon Lee; Jeoung Soo Lee; Ken Webb
Journal:  Biomacromolecules       Date:  2015-08-17       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.